A nurse is assessing a client who has anxiety and is taking buspirone. Which of the following findings should the nurse identify as an adverse effect of the medication?
Hypoglycemia
Bradycardia
Hypothermia
Hypokalemia
The Correct Answer is B
Buspirone is an anxiolytic agent that primarily acts as a serotonin 5-HT1A receptor agonist. It is thought to cause bradycardia by enhancing serotonergic activity in the brain, which can influence heart rate. The exact mechanism of how buspirone causes bradycardia is not fully understood, but it is believed to be related to its action on the central nervous system and its effects on neurotransmitters.
A,C,D- Not related to buspirone
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is B
Explanation
Hypoglycemia is a potential complication of parenteral nutrition, especially if the infusion rate is too high or if the infusion is interrupted. The nurse should promptly address hypoglycemia by administering IV dextrose, which will help raise the client's blood glucose levels.
A. Discontinuing the infusion may be necessary if the cause of hypoglycemia is related to the parenteral nutrition solution or if the infusion rate needs adjustment. However, the immediate priority is to treat the hypoglycemia by providing a glucose source.
C. Warming the formula to room temperature is not relevant to treating hypoglycemia. Warming the formula might be done for other reasons, such as improving tolerance or reducing discomfort during administration.
D. Obtaining arterial blood gases is not indicated for treating hypoglycemia. Arterial blood gases are typically obtained to assess oxygenation and acid-base balance, not glucose levels.
Correct Answer is D
Explanation
Filgrastim is a medication that stimulates the production of white blood cells (WBCs), particularly neutrophils, which are a type of WBC important for fighting infections. An increase in the WBC count would indicate that filgrastim is effectively stimulating the production of WBCs, which is desirable, especially in clients who are at risk of neutropenia (low WBC count) due to chemotherapy or other factors.
Monitoring potassium levels is important for clients receiving certain medications or experiencing conditions that can affect potassium balance, but it is not specifically related to filgrastim therapy.
BUN is a measure of kidney function and hydration status, but it is not typically monitored to evaluate the effectiveness of filgrastim treatment.
INR is a measure of blood clotting and is primarily monitored in clients receiving anticoagulant therapy, such as warfarin. It is not relevant to filgrastim therapy.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.